1. Home
  2. CING vs ASPS Comparison

CING vs ASPS Comparison

Compare CING & ASPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CING
  • ASPS
  • Stock Information
  • Founded
  • CING 2012
  • ASPS 1999
  • Country
  • CING United States
  • ASPS Luxembourg
  • Employees
  • CING N/A
  • ASPS N/A
  • Industry
  • CING Biotechnology: Pharmaceutical Preparations
  • ASPS Other Consumer Services
  • Sector
  • CING Health Care
  • ASPS Consumer Discretionary
  • Exchange
  • CING Nasdaq
  • ASPS Nasdaq
  • Market Cap
  • CING 15.3M
  • ASPS 17.8M
  • IPO Year
  • CING 2021
  • ASPS N/A
  • Fundamental
  • Price
  • CING $4.76
  • ASPS $0.65
  • Analyst Decision
  • CING Strong Buy
  • ASPS
  • Analyst Count
  • CING 2
  • ASPS 0
  • Target Price
  • CING $12.00
  • ASPS N/A
  • AVG Volume (30 Days)
  • CING 216.3K
  • ASPS 305.6K
  • Earning Date
  • CING 11-07-2024
  • ASPS 03-06-2025
  • Dividend Yield
  • CING N/A
  • ASPS N/A
  • EPS Growth
  • CING N/A
  • ASPS N/A
  • EPS
  • CING N/A
  • ASPS N/A
  • Revenue
  • CING N/A
  • ASPS $153,278,000.00
  • Revenue This Year
  • CING N/A
  • ASPS $14.04
  • Revenue Next Year
  • CING N/A
  • ASPS $33.86
  • P/E Ratio
  • CING N/A
  • ASPS N/A
  • Revenue Growth
  • CING N/A
  • ASPS 5.19
  • 52 Week Low
  • CING $1.80
  • ASPS $0.43
  • 52 Week High
  • CING $62.70
  • ASPS $3.36
  • Technical
  • Relative Strength Index (RSI)
  • CING 52.86
  • ASPS 44.10
  • Support Level
  • CING $4.27
  • ASPS $0.63
  • Resistance Level
  • CING $5.16
  • ASPS $1.04
  • Average True Range (ATR)
  • CING 0.42
  • ASPS 0.10
  • MACD
  • CING -0.01
  • ASPS -0.00
  • Stochastic Oscillator
  • CING 37.18
  • ASPS 5.80

About CING Cingulate Inc.

Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic areas to use PTR technology to develop future product candidates.

About ASPS Altisource Portfolio Solutions S.A.

Altisource Portfolio Solutions SA is an integrated service provider and marketplace for the real estate and mortgage industries. It operates via two reportable segments namely Servicer and Real Estate and Origination. The Servicer and Real Estate segment provides loan servicers and real estate investors with solutions and technologies that span the mortgage and real estate lifecycle. The Origination segment provides originators with solutions and technologies that span the mortgage origination lifecycle. Altisource primarily serves financial institutions, government-sponsored enterprises, and originators in the United States, with the majority of revenue flowing from field services and mortgage and real estate solutions.

Share on Social Networks: